BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
24 results:

  • 1. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast cancer to Radiotherapy.
    Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
    Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapy.
    Lim YC; Jensen KE; Aguilar-Morante D; Vardouli L; Vitting-Seerup K; Gimple RC; Wu Q; Pedersen H; Elbaek KJ; Gromova I; Ihnatko R; Kristensen BW; Petersen JK; Skjoth-Rasmussen J; Flavahan W; Rich JN; Hamerlik P
    Neuro Oncol; 2023 Feb; 25(2):248-260. PubMed ID: 35608632
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
    Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
    Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An Advanced
    Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
    ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long-Term Near-Infrared Signal Tracking of the Therapeutic Changes of Glioblastoma Cells in brain Tissue with Ultrasound-Guided Persistent Luminescent Nanocomposites.
    Cheng CL; Chan MH; Feng SJ; Hsiao M; Liu RS
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6099-6108. PubMed ID: 33507729
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Glutaric acidemia type 1: treatment and outcome of 168 patients over three decades.
    Strauss KA; Williams KB; Carson VJ; Poskitt L; Bowser LE; Young M; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Hailey J; Chopko S; Puffenberger EG; Brigatti KW; Miller F; Morton DH
    Mol Genet Metab; 2020 Nov; 131(3):325-340. PubMed ID: 33069577
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
    Cowman S; Fan YN; Pizer B; Sée V
    BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-nbs1 complex in glioma.
    Jiang Z; Guo Y; Miao L; Han L; Zhang W; Jiang Y
    J Biochem; 2019 Apr; 165(4):317-322. PubMed ID: 30535026
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Advances in the Surgical treatment of Neuroblastoma.
    Luo YB; Cui XC; Yang L; Zhang D; Wang JX
    Chin Med J (Engl); 2018 Oct; 131(19):2332-2337. PubMed ID: 30246719
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence and risk factors of leukoaraiosis from 4683 hospitalized patients: A cross-sectional study.
    Lin Q; Huang WQ; Ma QL; Lu CX; Tong SJ; Ye JH; Lin HN; Gu L; Yi KH; Cai LL; Tzeng CM
    Medicine (Baltimore); 2017 Sep; 96(39):e7682. PubMed ID: 28953609
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
    Broos K; Keyaerts M; Lecocq Q; Renmans D; Nguyen T; Escors D; Liston A; Raes G; Breckpot K; Devoogdt N
    Oncotarget; 2017 Jun; 8(26):41932-41946. PubMed ID: 28410210
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.
    Gholamin S; Mirzaei H; Razavi SM; Hassanian SM; Saadatpour L; Masoudifar A; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):866-879. PubMed ID: 28145567
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.
    Tonsing-Carter E; Bailey BJ; Saadatzadeh MR; Ding J; Wang H; Sinn AL; Peterman KM; Spragins TK; Silver JM; Sprouse AA; Georgiadis TM; Gunter TZ; Long EC; Minto RE; Marchal CC; Batuello CN; Safa AR; Hanenberg H; Territo PR; Sandusky GE; Mayo LD; Eischen CM; Shannon HE; Pollok KE
    Mol Cancer Ther; 2015 Dec; 14(12):2850-63. PubMed ID: 26494859
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Intraoperative photon therapy in combination with mapping of motoric cerebral cortex in surgery of metastatic tumours of functionally significant zones of the large hemispheres of the brain].
    Shcherbuk IuA; Shcherbuk AIu; Eroshenko ME; Tokarev SS; Ivanov VO; Dovgopolaia KA
    Vestn Khir Im I I Grek; 2014; 173(1):47-50. PubMed ID: 25055510
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integration of navigated brain stimulation data into radiosurgical planning: potential benefits and dangers.
    Picht T; Schilt S; Frey D; Vajkoczy P; Kufeld M
    Acta Neurochir (Wien); 2014 Jun; 156(6):1125-33. PubMed ID: 24744010
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adoptive cell transfer therapy for malignant gliomas.
    Ishikawa E; Takano S; Ohno T; Tsuboi K
    Adv Exp Med Biol; 2012; 746():109-20. PubMed ID: 22639163
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Ifosfamide or trofosfamide in patients with intraocular lymphoma.
    Jahnke K; Thiel E; Bechrakis NE; Willerding G; Kraemer DF; Fischer L; Korfel A
    J Neurooncol; 2009 Jun; 93(2):213-7. PubMed ID: 19099202
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas.
    Jiang H; Alonso MM; Gomez-Manzano C; Piao Y; Fueyo J
    Expert Rev Anticancer Ther; 2006 Nov; 6(11):1585-92. PubMed ID: 17134363
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The first molecular details of ALT in human tumor cells.
    Muntoni A; Reddel RR
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.